Intraocular Pressure Reduction With PhXA34, a New Prostaglandin Analogue, in Patients With Ocular Hypertension
Authors:
- Robert A. SchumerRSRobert A. Schumer
- Anders MarskAMAnders Marsk
- Jacqueline S. LustgartenJLJacqueline S. Lustgarten
- Janet B. SerleJSJanet B. Serle
- Johan StjernschantzJSJohan Stjernschantz
- Laszlo Z. BitoLBLaszlo Z. Bito
- Steven M. PodosSPSteven M. Podos
- 1 December 1992
- journal article
- clinical trial
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 110 (12) , 1733-1738
Abstract
Research from JAMA Ophthalmology — Intraocular Pressure Reduction With PhXA34, a New Prostaglandin Analogue, in Patients With Ocular HypertensionKeywords
This publication has 11 references indexed in Scilit:
- Effects of prostaglandin D2 and its analogue, BW245C, on intraocular pressure in humansGraefe's Archive for Clinical and Experimental Ophthalmology, 1991
- Additivity of Prostaglandin F2α-1-Isopropyl Ester to Timolol in Glaucoma PatientsOphthalmology, 1991
- The Effect of Adding Prostaglandin F2α-Isopropylester to Timolol in Patients With Open Angle GlaucomaArchives of Ophthalmology (1950), 1990
- Ocular effects of two different prostaglandin F2α estersActa Ophthalmologica, 1990
- Prostaglandin F2α increases uveoscleral outflow in the cynomolgus monkeyExperimental Eye Research, 1989
- Increased uveoscleral outflow as a possible mechanism of ocular hypotension caused by prostaglandin F2α-1-isopropylester in the cynomolgus monkeyExperimental Eye Research, 1989
- The Effects of Withdrawal of Timolol in Chronically Treated Glaucoma PatientsOphthalmology, 1988
- Topical Prostaglandin E 2 Effects on Normal Human Intraocular PressureJournal of Ocular Pharmacology and Therapeutics, 1988
- Ophthalmic beta-blockers since timololSurvey of Ophthalmology, 1987
- The effects of prostaglandin F2α in the human eyeGraefe's Archive for Clinical and Experimental Ophthalmology, 1985